These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6159320)

  • 21. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological analysis of B6.C-H-2bm12 (I-A mutant).
    Sandrin MS; McKenzie IF; Melvold RW; Hämmerling GJ
    Eur J Immunol; 1982 Mar; 12(3):205-9. PubMed ID: 6178596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One (H-2D2b) of the three Db region-controlled molecules (H-2D1b, H-2D2b, H-2Lb) is not detected in bm13 mutant.
    Iványi D; Démant P
    J Immunol; 1983 Sep; 131(3):1080-4. PubMed ID: 6604086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated cytotoxicity against allogeneic mutant H-2 antigens: restricted and nonrestricted responses.
    Nakamura I
    J Immunol; 1984 Jun; 132(6):2742-8. PubMed ID: 6202759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for mutation in an I-A gene.
    Hansen TH; Melvold RW; Arn JS; Sachs DH
    Nature; 1980 May; 285(5763):340-1. PubMed ID: 7374785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histocompatibility antigen changes associated with pink-eyed dilute (p) mutations.
    Wettstein PJ; Chapman V; Birkenmeier E
    Immunogenetics; 1988; 27(6):431-5. PubMed ID: 3286492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants.
    Isakov N; Bach FH
    Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological distinction of mutants B6.CH(zl) and B6.M505 from strain C57BL-6.
    Klein J; Hauptfeld M; Hauptfeld V
    J Exp Med; 1974 Oct; 140(4):1127-32. PubMed ID: 4139224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated lympholysis responses against autologous cells modified with haptenic sulfhydryl reagents. IV. Self-determinants recognized by wild-type anti-H-2Kb and H-2Db-restricted cytotoxic T cells specific for sulfhydryl and amino-reactive haptens are absent in certain H-2 mutant strains.
    Levy RB; Shearer GM
    J Immunol; 1982 Oct; 129(4):1525-9. PubMed ID: 6180015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical studies of H-2K antigens from a group of related mutants. I. Identification of a shared mutation in B6-H-2bm5 and B6-H-2bm16.
    Yamaga KM; Pfaffenbach GM; Pease LR; McGovern D; Nisizawa T; Melvold RW; Kohn HI; Nathenson SG
    Immunogenetics; 1983; 17(1):19-29. PubMed ID: 6826207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The definition of a new Ia antigenic specificity using the B6.C-H-2bml2 I-region mutant strain.
    Morgan GM; McKenzie IF; Melvold RW
    Immunogenetics; 1980 Jul; 11(1):1-6. PubMed ID: 6160095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of H-2 mutations to quantitate alloreactivity: Alloreactivity is strongest against H-2 antigens which are closet to self.
    Pimsler M; Forman J
    Immunogenetics; 1980; 11(2):111-21. PubMed ID: 6967859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vivo activity of cytotoxic lymphocytes directed against the product of gene H-2Kb and its mutant alleles].
    Nikonenko BV; Pospelov LE
    Biull Eksp Biol Med; 1981 Apr; 91(4):479-80. PubMed ID: 7020792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective loss of antigen-specific Ir gene function in IA mutant B6.C-H-2bm12 is an antigen presenting cell defect.
    Lin CC; Rosenthal AS; Passmore HC; Hansen TH
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6406-10. PubMed ID: 7031650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
    Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
    Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin graft enhancement studies with antigenic differences arising from the H-2K, H-2D, and H-2L loci.
    McKenzie IF; Henning MM; Morgan GM
    Transplantation; 1980 Jun; 29(6):439-43. PubMed ID: 6996234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of skin and heart graft rejection patterns in H-2 mutant mice.
    Davis WC; McKenzie IF; Melvold RW
    Transplantation; 1980 Mar; 29(3):189-92. PubMed ID: 6987783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.